home.aspx
 
. https://www.drugpatentwatch.com/blog/first-generic-launch-has-significant-first-mover-advantage-over-later-generic-drug-entrants/
blog article
FIRST GENERIC LAUNCH HAS SIGNIFICANT FIRST-MOVER ADVANTAGE OVER LATER GENERIC DRUG ENTRANTS
The first generic drug to make it to market after drug patent expiration enjoys a significant market share advantage over later arrivals. Furthermore, market share advantage – which can be up to 90% – holds for at least three years. READ MORE